Pfizer funnels $1B into Arvinas, with more in biobucks to come
22 Jul 2021 //
FIERCEBIOTECH
Pfizer pays $650 million upfront for rights to Arvinas` protein degrader ARV-471
22 Jul 2021 //
FIERCEBIOTECH
22 Jul 2021 //
FIERCEBIOTECH
22 Jul 2021 //
FIERCEBIOTECH